DirectorPfizerGroton, Connecticut, United States
Beyond the Conventional Paradigm: Rethinking the Necessity of Chronic Toxicity Studies for Biotherapeutics (S22)
Wednesday, November 20, 20243:45 PM - 5:00 PM CT
Industry Perspective of Value of Chronic Toxicity in Identifying Adverse Safety Signal in Human (S22-1)
Wednesday, November 20, 20243:45 PM - 4:05 PM CT